Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI Gains 5%; BSE HEALTHCARE Index Down 0.4%
Wed, 10 Jul 11:57

AMBALAL SARABHAI Gains 5%; BSE HEALTHCARE Index Down 0.4%Image source: Kameleon007 /www.istockphoto.com

AMBALAL SARABHAI share price has zoomed 5% and is presently trading at Rs 64.4.

Meanwhile, the BSE HEALTHCARE index is at 38,306.2 (down 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 4.1%) and KIMS (up 2.1%).

ALKEM LABORATORIES (down 2.4%) and HIKAL CHEMIC (down 2.0%) are among the top losers today.

Over the last one year, AMBALAL SARABHAI has moved up from Rs 27.2 to Rs 64.4, registering a gain of Rs 37.1 (up 136.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,306.2, registering a gain of 47.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.7%), Lupin (up 99.8%) and Cadila Healthcare (up 99.6%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,695.6 (down 0.8%).

The top losers among the BSE Sensex today are M&M (down 7.5%) and HCl Tech. (down 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 24,275.0 (down 0.7%). M&M and HCl Tech. are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,695.6, registering a gain of 14,351.4 points (up 22.0%).

AMBALAL SARABHAI Financial Update...

AMBALAL SARABHAI net profit grew 131.5% YoY to Rs 101 million for the quarter ended March 2024, compared to a profit of Rs 44 million a year ago. Net sales rose 22.3% to Rs 543 million during the period as against Rs 444 million in January-March 2023.

For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.

The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 58.8.


Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 5%; BSE HEALTHCARE Index Down 0.4%". Click here!